Association between injectable progestin-only contraceptives and HIV acquisition and HIV target cell frequency in the female genital tract in South African women: a prospective cohort study

Ross, 2012, Increased use of injectable contraception in sub-Saharan Africa, Afr J Reprod Health, 16, 68 Polis, 2014, Hormonal contraceptive methods and risk of HIV acquisition in women: a systematic review of epidemiological evidence, Contraception, 90, 360, 10.1016/j.contraception.2014.07.009 Ralph, 2015, Hormonal contraceptive use and women's risk of HIV acquisition: a meta-analysis of observational studies, Lancet Infect Dis, 15, 181, 10.1016/S1473-3099(14)71052-7 Morrison, 2015, Hormonal contraception and the risk of HIV acquisition: an individual participant data meta-analysis, PLoS Med, 12, e1001778, 10.1371/journal.pmed.1001778 Noguchi, 2015, Risk of HIV-1 acquisition among women who use different types of injectable progestin contraception in South Africa: a prospective cohort study, Lancet HIV, 2, e279, 10.1016/S2352-3018(15)00058-2 Shelton, 2012, Use of hormonal contraceptives and risk of HIV-1 transmission, Lancet Infect Dis, 12, 507, 10.1016/S1473-3099(12)70112-3 Huijbregts, 2014, Effect of progestins on immunity: medroxyprogesterone but not norethisterone or levonorgestrel suppresses the function of T cells and pDCs, Contraception, 90, 123, 10.1016/j.contraception.2014.02.006 Africander, 2011, Differential regulation of endogenous pro-inflammatory cytokine genes by medroxyprogesterone acetate and norethisterone acetate in cell lines of the female genital tract, Contraception, 84, 423, 10.1016/j.contraception.2011.06.006 Hughes, 2008, Cutting edge: progesterone regulates IFN-alpha production by plasmacytoid dendritic cells, J Immunol, 180, 2029, 10.4049/jimmunol.180.4.2029 Huijbregts, 2013, Hormonal contraception and HIV-1 infection: medroxyprogesterone acetate suppresses innate and adaptive immune mechanisms, Endocrinology, 154, 1282, 10.1210/en.2012-1850 Mitchell, 2014, Long-term effect of depot medroxyprogesterone acetate on vaginal microbiota, epithelial thickness and HIV target cells, J Infect Dis, 210, 651, 10.1093/infdis/jiu176 Sciaranghella, 2015, CCR5 expression levels in HIV-uninfected women receiving hormonal contraception, J Infect Dis, 212, 1397, 10.1093/infdis/jiv233 Anahtar, 2015, Cervicovaginal bacteria are a major modulator of host inflammatory responses in the female genital tract, Immunity, 42, 965, 10.1016/j.immuni.2015.04.019 Carnathan, 2015, Activated CD4+CCR5+ T cells in the rectum predict increased SIV acquisition in SIVGag/Tat-vaccinated rhesus macaques, Proc Natl Acad Sci USA, 112, 518, 10.1073/pnas.1407466112 Haase, 2010, Targeting early infection to prevent HIV-1 mucosal transmission, Nature, 464, 217, 10.1038/nature08757 Zhang, 1999, Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells, Science, 286, 1353, 10.1126/science.286.5443.1353 Kleynhans, 2013, The contraceptive depot medroxyprogesterone acetate impairs mycobacterial control and inhibits cytokine secretion in mice infected with Mycobacterium tuberculosis, Infect Immun, 81, 1234, 10.1128/IAI.01189-12 Morrison, 2014, Cervical inflammation and immunity associated with hormonal contraception, pregnancy, and HIV-1 seroconversion, J Acquir Immune Defic Syndr, 66, 109, 10.1097/QAI.0000000000000103 Bradshaw, 2013, Prevalent and incident bacterial vaginosis are associated with sexual and contraceptive behaviours in young Australian women, PLoS One, 8, e57688, 10.1371/journal.pone.0057688 Meditz, 2011, HLA-DR+ CD38+ CD4+ T lymphocytes have elevated CCR5 expression and produce the majority of R5-tropic HIV-1 RNA in vivo, J Virol, 85, 10189, 10.1128/JVI.02529-10 Stevenson, 1990, HIV-1 replication is controlled at the level of T cell activation and proviral integration, EMBO J, 9, 1551, 10.1002/j.1460-2075.1990.tb08274.x Haase, 2005, Perils at mucosal front lines for HIV and SIV and their hosts, Nat Rev Immunol, 5, 783, 10.1038/nri1706 Crook, 2014, Injectable and oral contraceptives and risk of HIV acquisition in women: an analysis of data from the MDP301 trial, Hum Reprod, 29, 1810, 10.1093/humrep/deu113 McCoy, 2013, Oral and injectable contraception use and risk of HIV acquisition among women in sub-Saharan Africa, AIDS, 27, 1001, 10.1097/QAD.0b013e32835da401 Saba, 2013, Productive HIV-1 infection of human cervical tissue ex vivo is associated with the secretory phase of the menstrual cycle, Mucosal Immunol, 6, 1081, 10.1038/mi.2013.2 Vishwanathan, 2011, High susceptibility to repeated, low-dose, vaginal SHIV exposure late in the luteal phase of the menstrual cycle of pigtail macaques, J Acquir Immune Defic Syndr, 57, 261, 10.1097/QAI.0b013e318220ebd3